Literature DB >> 19031376

Accidental dextromethorphan ingestions in children less than 5 years old.

Frank LoVecchio1, Anthony Pizon, Leslie Matesick, Sean O'Patry.   

Abstract

INTRODUCTION: The purpose of this study is to evaluate the clinical presentation of accidental dextromethorphan (DXM) ingestions in children <5 years old. Two consecutive years of poison center patient encounters were reviewed. Data including age, outcomes, amount of DXM ingested, co-ingestions, vital signs, clinical manifestations, hospital admissions, and mortality were abstracted. Data were analyzed using descriptive statistics. DISCUSSION: A total of 304 cases were identified with a mean age of 28.2 months (72% were > or =23 months). All cases co-ingested other products of over-the-counter cough and cold medications (i.e., acetaminophen, pseudoephedrine, guaifenesin, ibuprofen, various H1 receptor antagonists, and very infrequently ethanol). The mean DXM dose ingested was 35.0 mg (2.64 mg/kg). Of the patients, 62 (20.4%) experienced lethargy as the sole neurological sign and no patient had any cardiovascular abnormalities. Only 1 (13-monthold) patient, who ingested 3.2 mg/kg and presented with lethargy, was hospitalized and subsequently discharged 14 hours later. No deaths were recorded.
CONCLUSION: As demonstrated in our patient population, accidental ingestions of DXM in the pediatric patient did well with supportive care alone and rarely required inpatient treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19031376      PMCID: PMC3550111          DOI: 10.1007/bf03161208

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  10 in total

Review 1.  Recent trends of drug abuse and drug-associated deaths in Korea.

Authors:  Heesun Chung; Meejung Park; Eunyoung Hahn; Haeyoung Choi; Hwakyung Choi; Miae Lim
Journal:  Ann N Y Acad Sci       Date:  2004-10       Impact factor: 5.691

Review 2.  The role of dextromethorphan in pain control.

Authors:  A A Weinbroum; V Rudick; G Paret; R Ben-Abraham
Journal:  Can J Anaesth       Date:  2000-06       Impact factor: 5.063

3.  Massive dextromethorphan ingestion and abuse.

Authors:  T R Wolfe; E M Caravati
Journal:  Am J Emerg Med       Date:  1995-03       Impact factor: 2.469

4.  Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection.

Authors:  M S Jawad; R Eccles
Journal:  J Pharm Pharmacol       Date:  2000-09       Impact factor: 3.765

5.  A possible trend suggesting increased abuse from Coricidin exposures reported to the Texas Poison Network: comparing 1998 to 1999.

Authors:  S David Baker; Douglas J Borys
Journal:  Vet Hum Toxicol       Date:  2002-06

6.  Dose-response relationship with increasing doses of dextromethorphan for children with cough.

Authors:  Ian M Paul; Michele L Shaffer; Katharine E Yoder; Sarah A Sturgis; Mark S Baker; Cheston M Berlin
Journal:  Clin Ther       Date:  2004-09       Impact factor: 3.393

Review 7.  Abuse of over-the-counter dextromethorphan by teenagers.

Authors:  S Murray; T Brewerton
Journal:  South Med J       Date:  1993-10       Impact factor: 0.954

8.  Severe manifestations of coricidin intoxication.

Authors:  Thomas J Kirages; Harsh P Sulé; Mark B Mycyk
Journal:  Am J Emerg Med       Date:  2003-10       Impact factor: 2.469

9.  Fatal cold medication intoxication in an infant.

Authors:  Diane M Boland; Joseph Rein; Emma O Lew; W Lee Hearn
Journal:  J Anal Toxicol       Date:  2003-10       Impact factor: 3.367

10.  Antitussive activity of sigma-1 receptor agonists in the guinea-pig.

Authors:  Claire Brown; Malika Fezoui; William M Selig; Carl E Schwartz; James L Ellis
Journal:  Br J Pharmacol       Date:  2003-12-22       Impact factor: 8.739

  10 in total
  1 in total

1.  Infant Dextromethorphan and Dextrorphan Exposure via Breast Milk From Mothers Who Are CYP2D6 Extensive Metabolizers.

Authors:  Sara Shum; Aprajita Yadav; Emily Fay; Sue Moreni; Jennie Mao; Lindsay Czuba; Celine Wang; Nina Isoherranen; Mary F Hebert
Journal:  J Clin Pharmacol       Date:  2022-01-08       Impact factor: 2.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.